← Eichor
Study identifier: NCT07060378 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes

Condition: Lung Lesions · Mediastinal and Hilar Lymph Node Enlargement  ·  Sponsor: Shanghai Chest Hospital

PhaseNA
Planned participants250
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

Exploring the Clinical Application Value of Contrast Enhancement Features in CE-EBUS Images for the Diagnosis of Pulmonary Lesions and Intrapulmonary Lymph Nodes

This description comes directly from the study's public registry record.

Talk to the study team

Jiayuan sun  ·  +1511 86-021-22200000  ·  jysun1976@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Chest HospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07060378